Arcturus Therapeutics Ltd. Share-based Payment Arrangement, Expense
Arcturus Therapeutics Ltd. reported Share-based Payment Arrangement, Expense of $399.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2019-05-13
- Arcturus Therapeutics Ltd. share-based payment arrangement, expense for the quarter ending 2019-03-31 was $399.00K, a 1434.62% increase year-over-year.
- Arcturus Therapeutics Ltd. share-based payment arrangement, expense for the quarter ending 2018-03-31 was $26.00K.
- Arcturus Therapeutics Ltd. share-based payment arrangement, expense for fiscal 2018 was $1.26M, a 41.98% decline from fiscal 2017.
- Arcturus Therapeutics Ltd. share-based payment arrangement, expense for fiscal 2017 was $2.17M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|
| 2019-03-31 | $399.00K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $1.26M 10-K · filed 2019-03-18 | |
| 2018-03-31 | $26.00K 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $2.17M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $300.00K 20-F · filed 2018-05-14 | |
| 2015-12-31 | $99.00K 20-F · filed 2018-05-14 | |
| 2013-12-31 | $841.00K 20-F · filed 2014-03-28 | |
| 2012-12-31 | $26.00K 20-F · filed 2014-03-28 | |
| 2011-12-31 | $1.39M 20-F · filed 2014-03-28 |